BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2650139)

  • 1. Renal allograft rejection induces MHC class II upregulation in autologous kidney and liver of the recipient.
    Miller SM; Gupta R; Lee SH; Belitsky P
    Transplant Proc; 1989 Feb; 21(1 Pt 1):328. PubMed ID: 2650139
    [No Abstract]   [Full Text] [Related]  

  • 2. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of class I and class II major histocompatibility complex antigens (MHC) in rejecting human liver grafts.
    Gridelli B; Colledan M; Grendele M; Rossi G; Fassati LR; Galmarini D; Lazzaro A; Malavasi F; Ippoliti G
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2215-6. PubMed ID: 2652715
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunohistological analysis of renal allograft biopsies from cyclosporin-treated patients. Induced HLA-class II antigen expression does not exclude a diagnosis of cyclosporin nephrotoxicity.
    Fuggle SV; McWhinnie DL; Morris PJ
    Transpl Int; 1989 Oct; 2(3):123-8. PubMed ID: 2679626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for processing of WAG antigens by the RT1-D class II MHC molecules of PVG rats during kidney allograft rejection.
    Priestley CA; Spencer SS; Sawyer GJ; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1947-8. PubMed ID: 2389491
    [No Abstract]   [Full Text] [Related]  

  • 6. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
    Lin CY; Yen CY
    Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of renal mass on chronic kidney allograft rejection in rats.
    Heemann UW; Azuma H; Tullius SG; Mackenzie HS; Schmid C; Brenner BM; Tilney NL
    Transplant Proc; 1995 Feb; 27(1):549. PubMed ID: 7879094
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of interferon alpha in allograft rejection.
    Benizri EJ; Gugenheim J; Bernard G; Tovey MG
    Transplant Proc; 1995 Feb; 27(1):413. PubMed ID: 7879043
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of MHC class II expression in recipient tissues caused by allograft rejection.
    Belitsky P; Miller SM; Gupta R; Lee S; Ghose T
    Transplantation; 1990 Feb; 49(2):472-6. PubMed ID: 2305472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte transformation in renal lymphatics during canine allograft rejection.
    Cockett AT; Sakai A; Netto IC
    Invest Urol; 1973 Sep; 11(2):160-4. PubMed ID: 4580545
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of increased class II antigen expression in canine pancreas allograft rejection.
    Ekberg H; Allen RD; Chapman JR; Hawthorne WJ; Williamson P; Grierson JM; Stewart GJ; Little JM
    Transplant Proc; 1989 Feb; 21(1 Pt 1):510-2. PubMed ID: 2495618
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular analysis of graft survival in renal transplantation by DNA typing of HLA class II antigens.
    Tsuji K; Inoko H; Ando A; Matsuno N; Ikewaki N; Sato T; Ichikawa Y; Sonoda T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):662-3. PubMed ID: 3152706
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of HLA class II antigen induction and cellular infiltration in renal allograft rejection.
    McWhinnie DL; Fuggle SV; Azevedo LS; Carter NP; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):320-1. PubMed ID: 2650134
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms in organ allograft rejection. An experimental and clinical study.
    Claesson K
    Scand J Urol Nephrol Suppl; 1987; 103():1-42. PubMed ID: 3321417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of heart allograft rejection by serum from liver-grafted rats.
    Kamada N; Shinomiya T; Tamaki T
    Transplant Proc; 1987 Feb; 19(1 Pt 1):570-1. PubMed ID: 3274823
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal allograft rejection: protection of renal epithelium from natural killer cells by cytokine-induced up-regulation of class I major histocompatibility antigens.
    Lin Y; Proud G; Taylor RM; Kirby JA
    Immunology; 1993 Jun; 79(2):290-7. PubMed ID: 8344707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical renal transplantation.
    Porter KA
    Int Rev Exp Pathol; 1972; 11():73-176. PubMed ID: 4634009
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal target structures in acute allograft rejection.
    Leszczynski D; Laszczynska M; Halttunen J
    Transplant Proc; 1987 Feb; 19(1 Pt 1):378. PubMed ID: 3079159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.